Chiral N-Fmoc-β-amino alkyl isonitriles derived from amino acids: First synthesis and application in 1-substituted tetrazole synthesis

Journal of Organic Chemistry

Volumn 74, Issue 1, 2009, Pages 153-157

  Sureshbabu, Vommina V ^a   Narendra, N ^a   Nagendra, G ^a  

^a BANGALORE UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUPS; CHEMICAL EQUATIONS; ISONITRILES; NEW CLASSES; OPTICALLY ACTIVES; SYNTHESIS OF; SYNTHETIC APPLICATIONS; TRIMETHYLSILYL AZIDES;

AMINATION; AMINO ACIDS; CHEMICAL REACTIONS; ORGANIC ACIDS; SYNTHESIS (CHEMICAL);

AMINES;

AMINO ACIDS; AZIDES; CYCLIZATION; MOLECULAR CONFORMATION; NITRILES; STEREOISOMERISM; TETRAZOLES; TRIMETHYLSILYL COMPOUNDS;

EID: 58149302872     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo801527d     Document Type: Article

References (115)

1. Adam, W.; Bargon, R. M.; Bosio, S. G.; Schenk, W. A.; Stalke, D. J. Org. Chem. 2002, 67, 7037-7041.
2. Ripka, A. S.; Diaz, D. D.; Sharpless, K. B.; Finn, M. G. Org. Lett. 2003, 5, 1531-1533.
3. Chen, J. J.; Deshpande, S. V. Tetrahedron Lett. 2003, 44, 8873-8876.
4. (a) Neo, A. G.; Delgado, J.; Polo, C.; Marcaccini, S.; Marcos, C. F. Tetrahedron Lett. 2005, 46, 23-26.
5. (b) Neo, A. G.; Delgado, J.; Polo, C.; Marcaccini, S.; Marcos, C. F. Tetrahedron Lett. 2005, 46, 23-26.
6. Pri-Bar, I.; Schwartz, J. Chem. Commun. 1997, 347-348.
7. For addition to benzyne, see: (a) Rigby, J. H.; Laurent, S. J. Org. Chem. 1998, 63, 6742-6744.
8. For addition to pyridinium salts, see: (b) Williams, N. A. O.; Masdeu, C.; Diaz, J. L.; Lavilla, R. Org. Lett. 2006, 8, 5789-5792.
9. Finzi, P. V.; Arbasino, M. Tetrahedron Lett. 1965, 6, 4645-4646.
10. Jin, T.; Kamijo, S.; Yamamoto, Y. Tetrahedron Lett. 2004, 45, 9435-9437.
11. Kanazawa, C.; Kamijo, S.; Yamamoto, Y. J. Am. Chem. Soc. 2006, 128, 10662-10663.
12. For synthesis of pyrroles, see: (a) van Leusen, A. M.; Siderius, H.; Hoogenboom, B. E.; Daan van Leusen, Tetrahedron Lett. 1972, 13, 5337-5340.
13. For imidazoles, see: (b) Van Leusen, A. M.; Wildeman, J.; Oldenziel, O. H. J. Org. Chem. 1977, 42, 1153-1159.
14. For indole, see: (c) Campo, J.; García-Valverde, M.; Marcaccini, S.; Rojo, M. J.; Torroba, T. Org. Biomol. Chem. 2006, 4, 757-765.
15. For oxazolines, see: (d) van Daan, L.; van Albert, L. M. Synthesis 1991, 1991, 531-532.
16. Ruiz, J.; Garcia, G.; Mosquera, M. E. G.; Perandones, B. F.; Gonzalo, M. P.; Vivanco, M. J. Am. Chem. Soc. 2005, 127, 8584-8585.
17. For variations in the basic versions of the MCRs and post-condensational modifications, see: (a) Cristau, P.; Vors, J.-P.; Zhu, J. Org. Lett. 2001, 3, 4079-4082.
18. (b) Akritopoulou-Zanze, I.; Whitehead, A.; Waters, J. E.; Henry, R. F.; Djuric, S. W. Org. Lett. 2007, 9, 1299-1302.
19. (c) El Kaim, L.; Gizolme, M.; Grimaud, L.; Oble, J. Org. Lett. 2006, 8, 4019-4021.
20. (d) Paulvannan, K. J. Org. Chem. 2004, 69, 1207-1214.
21. For α-epoxy amides, see: (a) Said, S.; Andre, F. Synthesis 1983, 1983, 546-548.
22. (b) Bossio, R.; Marcos, C. F.; Marcaccini, S.; Pepino, R. Tetrahedron Lett. 1997, 38, 2519-2520.
23. For α-hydroxy amides, see: (c) Xia, Q.; Ganem, B. Org. Lett. 2002, 4, 16311634.
24. For lactones, see: (d) Falck, J. R.; Manna, S. Tetrahedron Lett. 1981, 22, 619-620.
25. For hydroxy furans, see: (e) Ricardo, B.; Stefano, M.; Roberto, P.; Tomas, T. Synthesis 1993, 1993, 783-784.
26. For thiophenes, see: (f) Bossio, R.; Marcaccini, S.; Pepino, R.; Torroba, T. J. Chem. Soc., Perkin Trans. 1 1996, 229-230.
27. For O-aryl phenols, see: (g) El Kaim, L.; Gizolme, M.; Grimaud, L. Org. Lett. 2006, 8, 5021-5023.
28. For combinatorial synthesis, see: (a) Armstrong, R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123-135.
29. For macroarrays, see: (b) Lin, Q.; O'Neill, J. C.; Blackwell, H. E. Org. Lett. 2005, 7, 4455-4458.
30. For macrocycles, see: (c) Beck, B.; Larbig, G.; Mejat, B.; Magnin-Lachaux, M.; Picard, A.; Herdtweck, E.; Domling, A. Org. Lett. 2003, 5, 1047-1050.
31. (d) Rivera, D. G.; Wessjohann, L. A. J. Am. Chem. Soc. 2006, 128, 7122-7123.
32. For natural product synthesis, see: (e) Fukuyama, T.; Robins, B. D.; Sachleben, R. A. Tetrahedron Lett. 1981, 22, 4155-4158.
33. (f) De Laszlo, S. E.; Williard, P. G. J. Am. Chem. Soc. 1985, 107, 199-203.
34. (g) Bauer, S. M.; Armstrong, R. W. J. Am. Chem. Soc. 1999, 121, 6355-6366.
35. For benzodiazepines, see: (a) Kotsuki, H.; Wakao, M.; Hayakawa, H.; Shimanouchi, T.; Shiro, M. J. Org. Chem. 1996, 61, 8915-8920.
36. (b) Keating, T. A.; Armstrong, R. W. J. Org. Chem. 1996, 61, 8935-8939.
37. (c) Ilyn, A. P.; Trifilenkov, A. S.; Kuzovkova, J. A.; Kutepov, S. A.; Nikitin, A. V.; Ivachtchenko, A. V. J. Org. Chem. 2005, 70, 1478-1481.
38. For thiazepines, see: (d) Marcaccini, S.; Miguel, D.; Torroba, T.; Garcia-Valverde, M. J. Org. Chem. 2003, 68, 3315-3318.
39. For diketopiperazine, see: (e) Kennedy, A. L.; Fryer, A. M.; Josey, J. A. Org. Lett. 2002, 4, 1167-1170.
40. For pyrolidinones, see: (f) Beck, B.; Picard, A.; Herdtweck, E.; Domling, A. Org. Lett. 2004, 6, 39-42.
41. For morpholines, see: (g) Kim, Y. B.; Choi, E. H.; Keum, G.; Kang, S. B.; Lee, D. H.; Koh, H. Y.; Kim, Y. Org. Lett. 2001, 3, 4149-4152.
42. For Ugi 4CR of isonitriles with acidic components such as azides, see: (a) Umkehrer, M.; Kolb, J.; Burdack, C.; Ross, G.; Hiller, W. Tetrahedron Lett. 2004, 45, 6421-6424.
43. 2, see: (b) Haslinger, E. Monatsh. Chem. 1978, 109, 749-750.
44. With cyanate, see: (c) Short, K. M.; Ching, B. W.; Mjalli, A. M. M. Tetrahedron Lett. 1996, 37, 7489-7492.
45. With thiocyanate, see: (d) Ugi, I.; Rosendalh, F. K.; Bodeshime, F. Liebigs Ann. Chem. 1963, 666, 54-61.
46. For condensation of isonitriles with epoxide and aziridines, tropylium ion and water, see: (a) Kern, O. T.; Motherwell, W. B. Chem. Commun. 2003, 2988-2989.
47. (b) Ugi, I.; Beiz, W.; Offermann, K. Chem. Ber. 1964, 97, 3008-3010.
48. For application of polyfunctionalized and convertible isonitriles in Ugi 4CR, see: (a) Linderman, R. J.; Binet, S.; Petrich, S. R. J. Org. Chem. 1999, 64, 336-337.
49. (b) Keating, T. A.; Armstrong, R. W. J. Am. Chem. Soc. 1995, 117, 7842-7843.
50. (a) Scheuer, P. Acc. Chem. Res. 1992, 25, 433-439.
51. (b) Fusetani, N. Curr. Org. Chem. 1997, 1, 127-152.
52. (a) Domling, A.; Ugi, I. Angew. Chem., Int. Ed. Engl. 2000, 39, 3168-3210.
53. (b) Domling, A. Chem. Rev. 2006, 106, 17-89.
54. (c) Ramon, D. J.; Yus, M. Angew. Chem., Int. Ed. Engl. 2005, 44, 1602-1634.
55. (d) Nair, V.; Rajesh, C.; Vinod, A. U.; Bindu, S.; Sreekanth, A. R.; Mathen, J. S.; Balagopal, L. Acc. Chem. Res. 2003, 36, 899-907.
56. (a) Ugi, I.; Domling, A.; Werner, B. Houben-Weyl: Synthesis of Peptides & Peptidomimetics, Multicomponent Reactions, Workbench ed.; Goodman, M., Felix, A., Moroder, L., Toniolo, C., Eds.; Thieme: Stuttgart, New York, 2001; Vol. E22a, pp 878-889.
57. (b) Waki, M.; Meienhofer, J. J. Am. Chem. Soc. 1977, 99, 6075-6082.
58. (a) Takashi, Y.; Yuichiro, O.; Yoshinori, Y.; Toshifumi, M.; Shigeru, K. Synthesis 1998, 1998, 991-998.
59. (b) Costa, S. P. G.; Maia, H. L. S.; Pereira-Lima, S. M. M. A. Org. Biomol. Chem. 2003, 1, 1475-1479.
60. (c) Jiang, W.-Q.; Costa, S. P. G.; Maia, H. L. S. Org. Biomol. Chem. 2003, 1, 3804-3810.
61. Hebach, C.; Kazmaier, U. Chem. Commun. 2003, 596-597.
62. (a) Kehagia, K.; Domling, A.; Ugi, I. Tetrahedron 1995, 51, 139-144.
63. (b) Domling, A.; Kehagia, K.; Ugi, I. Tetrahedron 1995, 51, 9519-9522.
64. (c) Gedey, S.; Van der Eycken, J.; Fulop, F. Org. Lett. 2002, 4, 1967-1969.
65. (d) Harriman, G. C. B. Tetrahedron Lett. 1997, 38, 5591-5594.
66. Chapman, T. M.; Davies, I. G.; Gu, B.; Block, T. M.; Scopes, D. I. C.; Hay, P. A.; Courtney, S. M.; McNeill, L. A.; Schofield, C. J.; Davis, B. G. J. Am. Chem. Soc. 2005, 127, 506-507.
67. Leon, F.; Rivera, D. G.; Wessjohann, L. A. J. Org. Chem. 2008, 73, 1762-1767.
68. 2NC] prepared starting from 1,2 diaminoethane, see: (a) Wang, W. H.; Zou, X. M.; Zhang, X.; Fu, Y. Q.; Xu, P. Chin. Chem. Lett. 2005, 16, 585-588.
69. (b) Maison, W.; Schemminger, I.; Westerhoff, O.; Martens, J. Bioorg. Med. Chem. Lett. 1999, 9, 581-584.
70. (c) Domling, A.; Chi, K.-Z.; Barrere, M. Bioorg. Med. Chem. Lett. 1999, 9, 2871-2874.
71. (d) Domling, A. Nucleosides Nucleotides 1998, 17, 1667-1670.
72. (e) Domling, A.; Richter, W. Nucleosides Nucleotides 1997, 16, 1753-1756.
73. (f) Xu, P.; Zhang, T.; Wang, W.; Zou, X.; Zhang, X.; Fu, Y. Synthesis 2003, 2003, 1171-1176.
74. (g) Wang, W. H.; Zhang, T.; Xu, P. Chinese Pharm. Sci. 2003, 12, 66-70;
75. Chem. Abstr. 2003, 140, 199708.
76. For non-proteinogenic amino acids, see: (a) Groger, H.; Hatam, M.; Martens, J. Tetrahedron 1995, 51, 7173-7180.
77. For N-hydroxy peptides, see: (b) Zinner, G.; Moderhack, D.; Kliegel, W. Chem. Ber. 1969, 102, 2536-2516.
78. Abbas, M.; Bethke, J.; Wessjohann, L. A. Chem. Commun. 2006, 541-543.
79. Golebiowski, A.; Jozwik, J.; Klopfenstein, S. R.; Colson, A.-O.; Grieb, A. L.; Russell, A. F.; Rastogi, V. L.; Diven, C. F.; Portlock, D. E.; Chen, J. J. J. Comb. Chem. 2002, 4, 584-590.
80. Kim, S. W.; Bauer, S. M.; Armstrong, R. W. Tetrahedron Lett. 1998, 39, 6993-6996.
81. Kim, S. W.; Shin, Y. S.; Ro, S. Bioorg. Med. Chem. Lett. 1998, 8, 1665-1669.
82. Burger, K.; Mutze, K.; Hollweck, W.; Koksch, B. Tetrahedron 1998, 54, 5915-5928.
83. Semple, J. E.; Owens, T. D.; Nguyen, K.; Levy, O. E. Org. Lett. 2000, 2, 2769-2772.
84. (a) Kazmaier, U.; Ackermann, S. Org. Biomol. Chem. 2005, 3, 3184-3187.
85. (b) Umkehrer, M.; Kolb, J.; Burdack, C.; Hiller, W. Synlett 2005, 2005, 79-82.
86. Domling, A.; Katrin, I. Synthesis 2005, 2005, 662-667.
87. Kennedy, A. L.; Fryer, A. M.; Josey, J. A. Org. Lett. 2002, 4, 1167-1170.
88. (a) Carpino, L. A.; Beyermann, M.; Wenschuh, H.; Bienert, M. Acc. Chem. Res. 1996, 29, 268-274.
89. For synthesis, isolation, and characterization of Fmoc-amino acid/peptide acid derived stable isocyanates, see: (b) Patil, B. S.; Vasanthakumar, G.-R.; Suresh Babu, V. V. J. Org. Chem. 2003, 68, 7274-7280.
90. (c) Sureshbabu, V. V.; Patil, B. S.; Venkataramanarao, R. J. Org. Chem. 2006, 71, 7697-7705.
91. Sudarshan, N. S.; Narendra, N.; Hemantha, H. P.; Sureshbabu, V. V. J. Org. Chem. 2007, 72, 9804-9807.
92. For employing phosgene surrogates, see: (a) Skorna, G.; Ugi, I. Angew. Chem., Int. Ed. Engl. 1977, 16, 259-260.
93. (b) Eckert, H.; Forster, B. Angew. Chem., Int. Ed. Engl. 1987, 26, 894-895.
94. 3, see: (c) Roland, O.; Rudolf, H.; Ugi, I. Synthesis 1985, 1985, 400-402.
95. 3, see: (d) Appel, R.; Kleinstück, R.; Ziehn, K.-D. Angew. Chem., Int. Ed. Engl. 1971, 10, 132-134.
96. For the use of N-carboalkoxysulfamate esters in dehydration reactions and the inner salt of methyl(carboxysulfamoyl)triethyl ammonium hydroxide [Burgess reagent] as dehydrating agent, see: (a) Atkins, G. M., Jr.; Burgess, E. M. J. Am. Chem. Soc. 1968, 90, 4744-4745.
97. (b) Burgess, E. M., Jr.; Taylor, E. A. J. Am. Chem. Soc. 1970, 92, 5224-5225.
98. (c) Burgess, E. M., Jr.; Taylor, E. A. J. Org. Chem. 1973, 38, 26-31.
99. (d) Burgess, E. M.; Penton, H. R.; Taylor, E. A.; Williams, W. M. Organic Synthesis; Wiley: New York, 1987; Collect. Vol. VI, pp 788-791.
100. For a few recent synthetic applications of Burgess reagent, see: (e) Nicolaou, K. C.; Huang, X.; Snyder, S. A.; Rao, P. B.; Bella, M., Dr.; Reddy, M. V. Angew. Chem., Int. Ed. 2002, 41, 834-838.
101. (f) Nicolaou, K. C.; Snyder, S. A.; Nalbandian, A. Z.; Longbottom, D. A. J. Am. Chem. Soc. 2004, 126, 6234-6235.
102. Creedon, S. M.; Crowley, H. K.; McCarthy, D. G. J. Chem. Soc., Perkin Trans. 1 1998, 1015-1018.
103. 2, and chlorothionoformate, see: (a) Bose, D. S.; Goud, P. R. Tetrahedron Lett. 1999, 40, 747-748, and references therein.
104. For isosters, see: (a) Wittenberger, S. J. Org. Prep. Proced. Int. 1994, 26, 499-531.
105. For asymmetric catalysis, see: (b) Torii, H.; Nakadai, M.; Ishihara, K.; Saito, S.; Yamamoto, H. Angew. Chem., Int. Ed. Engl. 2004, 43, 1983-1986.
106. (c) Chowdari, N. S.; Ahmad, M.; Albertshofer, K.; Tanaka, F.; Barbas, C. F. Org. Lett. 2006, 8, 2839-2842.
107. For pharmaceutical importance, see: (d) Bavetsias, V.; Marriott, J. H.; Melin, C.; Kimbell, R.; Matusiak, Z. S.; Boyle, F. T.; Jackman, A. L. J. Med. Chem. 2000, 43, 1910-1926.
108. For metallopeptide stabilization, see: (e) Lee, K.; Kim, Y.-J.; Baeck, K. K. J. Organomet. Chem. 2005, 690, 4319-4329.
109. (a) Sureshbabu, V. V.; Venkataramanarao, R.; Naik, S. A.; Chennakrishnareddy, G. Tetrahedron Lett. 2007, 48, 7038.
110. (b) Demko, Z. P.; Sharpless, K. B. Org. Lett. 2002, 4, 2525-2527.
111. Wulff, H.; Miller, M. J.; Hansel, W.; Grissmer, S.; Cahalan, M. D.; Chandy, K. G. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 8151-8156.
112. (a) For Smac peptide mimetics see: Harran, P. G.; Wang, X.; De Brabander, K.; Li, L.; Thomas, M.; Suzuki, H. U. S. Patent Appl. 2005/0197403 A1, 2005.
113. (b) For serotonin agonists, see: Street, L. J.; Baker, R.; Davey, W. B.; Guiblin, A. R.; Jelley, R. A.; Reeve, A. J.; Routledge, H.; Sternfeld, F.; Watt, A. P.; Beer, M. S.; Middlemiss, D. N.; Noble, A. J.; Stanton, J. A.; Scholey, K.; Hargreaves, R. J.; Sohal, B.; Graham, M. I.; Matassat, V. G. J. Med. Chem. 1995, 38, 799-1810.
114. (a) Potewar, T. M.; Siddiqui, S. A.; Lahoti, R. J.; Srinivasasn, K. V. Tetrahedron Lett. 2007, 48, 1721-1724.
115. For tetrazole derivatives of carbohydrates, see: (b) Couri, M. R.; Luduvico, I.; Santos, L.; Alves, R.; Prado, M. A.; Gil, R. F. Carbohydr. Res. 2007, 342, 1096-1100.